View Older Stories View More Recent Stories

Oct 18, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 16, 2024 08:04AM Alnylam Pharma (ALNY) Submits Regulatory Application to the European Medicines Agency for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
Oct 11, 2024 06:20AM Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 08:21AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 07:56AM BMO Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 07:43AM Piper Sandler Reiterates Overweight Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 06:25AM Oppenheimer Reiterates Perform Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 05:50AM Citi Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 05:36AM Goldman Sachs Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 05:30AM BofA Securities Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 9, 2024 07:03AM Alnylam Pharma (ALNY) Submits sNDA to FDA for Vutrisiran for the Treatment of Transthyretin Amyloidosis with Cardiomyopathy
Oct 1, 2024 06:49AM Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 30, 2024 08:35AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 30, 2024 07:52AM Piper Sandler Reiterates Overweight Rating on Alnylam Pharmaceuticals (ALNY)
Sep 30, 2024 05:42AM Goldman Sachs Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 27, 2024 06:01AM BofA Securities Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 16, 2024 08:41AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 4, 2024 05:22AM Alnylam Pharmaceuticals (ALNY) PT Raised to $307 at BofA Securities
Sep 3, 2024 08:05AM Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 3, 2024 07:37AM Oppenheimer Reiterates Perform Rating on Alnylam Pharmaceuticals (ALNY)
Sep 3, 2024 07:29AM Wolfe Research Reiterates Peerperform Rating on Alnylam Pharmaceuticals (ALNY)
Sep 3, 2024 07:24AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 3, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 3, 2024 05:25AM Barclays Reiterates Overweight Rating on Alnylam Pharmaceuticals (ALNY)
Sep 3, 2024 05:18AM Citi Reiterates Neutral Rating on Alnylam Pharmaceuticals (ALNY)
Aug 30, 2024 08:50AM Alnylam Pharma (ALNY) Management Said There Was a Typo Error on Discussant Slide - Stat
Aug 30, 2024 08:21AM BMO Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY) following HELIOS-B readout
Aug 30, 2024 07:58AM Stifel Reiterates Alnylam Pharmaceuticals (ALNY) at Buy following HELIOS-B readout, 'full HELIOS-B data look strong'
Aug 30, 2024 07:39AM Ainylam Pharmaceuticals shares tumble following study results, BridgeBio Pharma rises
Aug 30, 2024 06:11AM Alnylam Pharma (ALNY) Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran
Aug 27, 2024 07:47AM BMO Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
Aug 26, 2024 06:27AM RBC Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
Aug 16, 2024 08:49AM Goldman Sachs Upgrades Alnylam Pharmaceuticals (ALNY) to Buy
Aug 13, 2024 10:01AM BMO Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
Aug 7, 2024 10:00AM Eight defensive growth stocks to own right now
Aug 2, 2024 07:00AM Alnylam Pharmaceuticals (ALNY) PT Raised to $366 at Canaccord Genuity
Aug 2, 2024 06:21AM Alnylam Pharmaceuticals (ALNY) PT Raised to $300 at RBC Capital
Aug 1, 2024 08:14AM Alnylam Pharma (ALNY) Tops Q2 EPS by $1.61
Jul 16, 2024 05:50AM BMO Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
Jul 9, 2024 07:00PM 2Q24 U.S. biotech earnings preview
Jul 8, 2024 10:54AM Alnylam Pharmaceuticals (ALNY) PT Raised to $357 at Canaccord Genuity
Jun 28, 2024 05:18AM Alnylam Pharmaceuticals (ALNY) PT Raised to $288 at UBS
Jun 27, 2024 08:10AM Alnylam Pharmaceuticals (ALNY) PT Raised to $295 at Stifel
Jun 27, 2024 06:12AM Alnylam Pharmaceuticals (ALNY) PT Raised to $265 at RBC Capital, 'we remain buyers'
Jun 25, 2024 10:32AM Increasing unusual call option volume: ALNY ZI MCRB BURL FTAI BRCC ENVX OLLI
Jun 25, 2024 10:22AM Alnylam Pharmaceuticals (ALNY) PT Raised to $282 at TD Cowen
Jun 25, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Jun 24, 2024 12:28PM Alnylam Pharmaceuticals (ALNY) PT Raised to $250 at Morgan Stanley
Jun 24, 2024 12:03PM Midday movers: Apple, Eli Lilly rise; Coinbase falls
Jun 24, 2024 11:41AM TD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO)
View More Recent Stories View Older Stories